ORGS: Orgenesis Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 10.97
Enterprise Value ($M) 25.87
Book Value ($M) -23.93
Book Value / Share -4.60
Price / Book -0.46
NCAV ($M) -51.10
NCAV / Share -9.83
Price / NCAV -0.21

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.36
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.07
Current Ratio 0.07

Balance Sheet (mrq) ($M)
Current Assets 2.52
Assets 29.69
Liabilities 53.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
12-04 13G/A JSAF Holdings, LLC 9.99
12-04 13G/A Safier Jacob 9.99 -89.65

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA
2024-04-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-04-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-04-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

(click for more detail)

Similar Companies
OMGAQ – Omega Therapeutics, Inc. ONCSQ – OncoSec Medical Incorporated
OPHLF – Ono Pharmaceutical Co., Ltd. OTLC – Oncotelic Therapeutics, Inc.
OTSKF – Otsuka Holdings Co., Ltd.


Financial data and stock pages provided by
Fintel.io